浙江医药 (600216.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(浙江医药)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 5,876,518,447.273,937,942,897.552,007,935,140.538,115,804,648.336,123,873,142.304,117,668,029.842,184,192,085.97
 营业收入(元) 5,876,518,447.273,937,942,897.552,007,935,140.538,115,804,648.336,123,873,142.304,117,668,029.842,184,192,085.97
二、营业总成本(元) 5,607,285,954.163,702,739,461.731,902,448,267.477,482,025,427.215,498,607,942.853,600,913,520.741,884,014,155.71
 营业成本(元) 3,903,509,995.662,605,226,938.661,330,219,880.045,318,274,426.323,933,262,299.572,588,929,436.041,358,513,300.38
 研发费用(元) 607,134,841.28430,102,351.06166,709,820.29809,279,317.22555,393,836.63355,076,062.82172,997,815.13
 营业税金及附加(元) 53,539,115.0533,566,826.8816,262,945.5269,862,910.1245,580,926.6028,703,993.3918,431,560.34
 销售费用(元) 755,074,640.99468,865,070.02271,974,096.37890,508,132.92706,835,125.12449,319,399.84233,376,117.46
 管理费用(元) 308,718,579.07198,449,307.21105,835,577.77432,066,700.89294,713,826.01190,196,737.8481,903,341.59
 财务费用(元) -20,691,217.89-33,471,032.1011,445,947.48-37,966,060.26-37,178,071.08-11,312,109.1918,792,020.81
  其中:利息费用(元) 21,282,957.9614,409,347.127,203,313.9233,170,102.0525,376,259.2016,728,175.858,524,399.73
  其中:利息收入(元) 12,584,586.898,130,371.022,530,101.7213,176,958.609,100,133.886,080,337.803,188,350.66
三、其他经营收益
 加:公允价值变动收益(元) -4,714,569.075,315,635.2611,310,125.76-23,881,330.47-25,735,861.16-24,912,733.98-26,028,195.35
 加:投资收益(元) -603,058.292,705,548.933,118,443.22-32,625,966.3327,662,634.326,664,001.0517,089,432.40
  其中:对联营企业和合营企业的投资收益(元) -6,995,221.72-4,254,879.48-1,695,619.70-3,806,190.10-1,204,045.13-1,926,498.80-1,783,407.33
 资产处置收益(元) -752,178.79-62,488.31-25,198.613,309,480.043,023,408.893,140,496.753,338,641.96
 资产减值损失(元) -64,500,663.90-34,422,727.59-13,615,292.64-117,141,414.11-85,267,375.67-66,851,489.96-20,471,725.18
 信用减值损失(元) 17,385,441.5822,751,501.94-8,629,019.36-25,088,386.86-89,449,530.46-44,810,129.65-12,539,971.82
 其他收益(元) 43,206,763.3321,325,743.307,656,564.0966,264,351.3346,046,902.1028,173,010.166,451,538.74
四、营业利润(元) 259,254,227.97252,816,649.35105,302,495.52504,615,954.72501,545,377.47418,157,663.47268,017,651.01
 加:营业外收入(元) 24,464,480.6524,326,258.06170,021.272,126,365.271,532,366.30473,811.89141,338.41
 减:营业外支出(元) 15,336,121.6914,227,809.233,109,669.5015,353,899.3113,252,836.818,468,100.032,662,839.00
五、利润总额(元) 268,382,586.93262,915,098.18102,362,847.29491,388,420.68489,824,906.96410,163,375.33265,496,150.42
 减:所得税费用(元) 87,516,878.6175,914,587.6218,290,631.21128,774,678.73131,925,594.6597,857,880.7050,651,710.09
六、净利润(元) 180,865,708.32187,000,510.5684,072,216.08362,613,741.95357,899,312.31312,305,494.63214,844,440.33
(一)按经营持续性分类
  持续经营净利润(元) 180,865,708.32187,000,510.5684,072,216.08362,613,741.95357,899,312.31312,305,494.63214,844,440.33
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 301,338,595.24272,261,125.88113,551,849.15539,570,083.23484,454,300.43390,587,728.16260,543,171.58
  少数股东损益(元) -120,472,886.92-85,260,615.32-29,479,633.07-176,956,341.28-126,554,988.12-78,282,233.53-45,698,731.25
 扣除非经常性损益后的净利润(元) 258,816,175.82238,949,411.9998,141,772.45514,239,703.61438,148,124.86380,737,753.77255,229,752.62
七、每股收益
 一、基本每股收益(元) 0.310.280.120.560.510.410.27
 二、稀释每股收益(元) 0.310.280.120.560.510.410.27
八、其他综合收益(元) 5,759,087.0913,968,045.401,258,936.909,419,617.42-1,296,159.46-2,944,866.17-4,101,040.24
 归属于母公司股东的其他综合收益(元) 5,482,416.3213,260,059.251,208,686.098,720,202.35-1,593,373.88-2,921,357.08-3,779,671.73
 归属于少数股东的其他综合收益(元) 276,670.77707,986.1550,250.81699,415.07297,214.42-23,509.09-321,368.51
九、综合收益总额(元) 186,624,795.41200,968,555.9685,331,152.98372,033,359.37356,603,152.85309,360,628.46210,743,400.09
 归属于母公司所有者的综合收益总额(元) 306,821,011.56285,521,185.13114,760,535.24548,290,285.58482,860,926.55387,666,371.08256,763,499.85
 归属于少数股东的综合收益总额(元) -120,196,216.15-84,552,629.17-29,429,382.26-176,256,926.21-126,257,773.70-78,305,742.62-46,020,099.76
公告日期 2023-10-262023-08-242023-04-262023-04-262022-10-272022-08-262022-04-27
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院